At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DNA Ginkgo Bioworks Holdings Inc.
Market Closed 10-09 16:00:00 EDT
13.00
+1.66
+14.64%
盘后13.02
+0.02+0.15%
19:59 EDT
High13.56Low11.48Vol4.52M
Open11.76D1 Closing11.34Amplitude18.30%
Mkt Cap875.42MTradable Cap648.35MTotal Shares67.34M
T/O57.91MT/O Rate9.06%Tradable Shares49.87M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Ginkgo Bioworks to provide autonomous lab access to NSF X-Labs researchers
TIPRANKS  ·  10-09 04:16
Ginkgo Bioworks to provide autonomous lab access to NSF X-Labs researchers
Ginkgo Bioworks Holdings - to Offer Protein Testing Services to Nsf X-Labs Teams
THOMSON REUTERS  ·  10-09 04:10
Ginkgo Bioworks Holdings - to Offer Protein Testing Services to Nsf X-Labs Teams
Ginkgo Bioworks Holdings - to Provide Cloud Lab Time and Remote Access for Nsf X-Labs Teams
THOMSON REUTERS  ·  10-09 04:10
Ginkgo Bioworks Holdings - to Provide Cloud Lab Time and Remote Access for Nsf X-Labs Teams
Ginkgo Bioworks to Provide Autonomous Lab Access to Nsf X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
THOMSON REUTERS  ·  10-09 04:10
Ginkgo Bioworks to Provide Autonomous Lab Access to Nsf X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
Ginkgo Bioworks Probes Unauthorized Access to Legacy Cloud Data
Reuters  ·  10-09 04:08
Ginkgo Bioworks Probes Unauthorized Access to Legacy Cloud Data
Araceli Biosciences Integrates Endeavor Imaging System into Ginkgo Bioworks’ Nebula Autonomous Lab
Reuters  ·  10-08 18:02
Araceli Biosciences Integrates Endeavor Imaging System into Ginkgo Bioworks’ Nebula Autonomous Lab
Ginkgo Bioworks CFO Steven P. Coen Disposes of $36,045 in Common Shares
Reuters  ·  10-08 05:01
Ginkgo Bioworks CFO Steven P. Coen Disposes of $36,045 in Common Shares
From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run
Bellwether Stocks Movement  ·  10-06
From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run
Candel Therapeutics to Present at the SITC 2026 Annual Meeting
GlobeNewswire  ·  10-02
Candel Therapeutics to Present at the SITC 2026 Annual Meeting
Novartis Bets $7.8 Billion On MRNA Beyond Vaccines
Options & Short Sell  ·  10-02
Novartis Bets $7.8 Billion On MRNA Beyond Vaccines
From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot
Tech News Roundup  ·  10-02
From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot
Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium
MT Newswires Live  ·  09-29
Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium
U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify
Reuters  ·  09-22
U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify
Ginkgo Bioworks Director Christian O. Henry Disposes of 5,000 Common Shares Worth $35,405
Reuters  ·  09-17
Ginkgo Bioworks Director Christian O. Henry Disposes of 5,000 Common Shares Worth $35,405
Ginkgo Datapoints Announces Partnership with Tunelab to Close the Gap Between AI Models and Lab Data
THOMSON REUTERS  ·  09-16
Ginkgo Datapoints Announces Partnership with Tunelab to Close the Gap Between AI Models and Lab Data
Ginkgo Datapoints Partners with Lilly TuneLab on AI-Driven Drug Discovery Lab Data Generation
Reuters  ·  09-16
Ginkgo Datapoints Partners with Lilly TuneLab on AI-Driven Drug Discovery Lab Data Generation
Ginkgo Bioworks Holdings, - Awarded Subcontract for up to $17.50 Mln Under Arpa-H Give Program
THOMSON REUTERS  ·  09-10
Ginkgo Bioworks Holdings, - Awarded Subcontract for up to $17.50 Mln Under Arpa-H Give Program
Ginkgo Bioworks Joins Waterfall Scientific-Led ARPA-H Consortium to Build Autonomous RNA Drug Manufacturing System
Reuters  ·  09-10
Ginkgo Bioworks Joins Waterfall Scientific-Led ARPA-H Consortium to Build Autonomous RNA Drug Manufacturing System
Press Release: Candel Therapeutics Appoints Martine Zimmermann, PharmD, to Its Board of Directors
Dow Jones  ·  09-10
Press Release: Candel Therapeutics Appoints Martine Zimmermann, PharmD, to Its Board of Directors
Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips
AI Industry Frontlines  ·  09-08
Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips

Introduction

Company Name.
Ginkgo Bioworks Holdings Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Issue price:
--